The key insight is that the belly fat lost during a well-run peptide cycle tends to stay off if the underlying metabolic improvements are maintained through continued nutrition and exercise habits
Microdose semaglutide has emerged as an accessible entry point for patients exploring GLP-1 therapy, with initial doses typically ranging from 0.25 mg to 0.5 mg weekly
Some people may find they respond better to one drug than others due to these different mechanisms of action
Population diversity is also limited, with few studies including older adults, men with obesity, or individuals from different ethnic backgrounds
Medications like Ozempic, Wegovy, Saxenda, Mounjaro, and Zepbound have become household names in the treatment of obesity and type 2 diabetes
Those without a history of severe allergic reactions to any component of the treatment